{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:07:58Z","timestamp":1789204078973,"version":"build-2803163510"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"unspecified","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Collaborative Research Fund of Hong Kong","award":["C7009-19G"],"award-info":[{"award-number":["C7009-19G"]}]},{"name":"Collaborative Research Fund of Hong Kong","award":["C7101-23W"],"award-info":[{"award-number":["C7101-23W"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Ment Health"],"accepted":{"date-parts":[[2026,8,20]]},"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Conflicting evidence from observational studies and randomised trials has created uncertainty about the association between attention-deficit\/hyperactivity disorder (ADHD) medication use and self-harm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the risk of incident self-harm associated with use of ADHD medication across multiple healthcare systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a multinational self-controlled case series study using a common data modelling approach to assess the risk of self-harm among individuals treated with ADHD medication across population-based databases from Hong Kong, New Zealand, South Korea, Taiwan and the United Kingdom. We included individuals who initiated ADHD medication and had a record of self-harm between 2001\u20132020. Incidence rate ratios (IRRs) for self-harm were calculated using conditional Poisson regression, comparing three risk periods of ADHD medication exposure (ie, the 90 days before medication initiation, the first 90 days of medication use and the subsequent treatment period) to non-exposure periods. Adjusted IRRs and 95% CIs were estimated for various risk periods. Estimates from each site were pooled using a random-effects model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>A total of 461\u2009024 individuals with at least one prescription for ADHD medication were included, of whom 6847 had an incident self-harm event during the observation period. The risk was highest during the 90 days before medication initiation (pooled adjusted IRR: 2.58; 95%\u2009CI 2.12 to 3.13), followed by the first 90 days of medication use (pooled adjusted IRR: 1.78; 95%\u2009CI 1.23 to 2.57), and lowest in the subsequent treatment period (pooled adjusted IRR: 1.27; 95%\u2009CI 1.01 to 1.60). Results were consistent across included databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>While the use of ADHD medication was associated with self-harm, the highest risk occurred during the unexposed period immediately before starting treatment. The consistent findings across various health systems do not support ADHD medications as the main driver of self-harm. Instead, the increased risk observed prior to treatment may be related to untreated ADHD features.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical implications<\/jats:title>\n                    <jats:p>Although our findings provide reassurance that ADHD medications do not appear to be the main driver of the increased self-harm risk, the persistently elevated risk highlights the need for ongoing clinical monitoring and counselling before and during treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjment-2026-302819","type":"journal-article","created":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:25:21Z","timestamp":1789201521000},"page":"e302819","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["ADHD medication use and risk of self-harm: a multinational self-controlled case series study"],"prefix":"10.1136","volume":"29","author":[{"given":"Adrienne Y L","family":"Chan","sequence":"first","affiliation":[{"name":"Aston Pharmacy School, Aston University, West Midlands, Birmingham, USA"},{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede","family":"Beyene","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Grafton, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-4131","authenticated-orcid":false,"given":"Sohee","family":"Park","sequence":"additional","affiliation":[{"name":"Aston Pharmacy School, Aston University, West Midlands, Birmingham, USA"},{"name":"School of Pharmacy, Sungkyunkwan University, Suwon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Yao","family":"Shen","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4850-566X","authenticated-orcid":false,"given":"Andrew S C","family":"Yuen","sequence":"additional","affiliation":[{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London, London, England, USA"},{"name":"Centre for Medicines Optimisation Research and Education (CMORE), University College London Hospitals NHS Foundation Trust, London, England, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie H T W","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu Lun","family":"Au Yeung","sequence":"additional","affiliation":[{"name":"School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7602-9470","authenticated-orcid":false,"given":"Esther W","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3017-9737","authenticated-orcid":false,"given":"David","family":"Coghill","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia"},{"name":"Department of Psychiatry, Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine S L","family":"Chui","sequence":"additional","affiliation":[{"name":"School of Nursing, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong SAR"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Cook","sequence":"additional","affiliation":[{"name":"Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[{"name":"Center for Health Services Research, Institute for Health, Health Care Policy and Aging Research, Rutgers University, New Brunswick, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Ip","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9992-6609","authenticated-orcid":false,"given":"Tatia M C","family":"Lee","sequence":"additional","affiliation":[{"name":"InnoCentre of Clinical Neuropsychology, The University of Hong Kong, Hong Kong, Hong Kong"},{"name":"Laboratory of Neuropsychology and Human Neuroscience, The University of Hong Kong, Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallis C Y","family":"Lau","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR"},{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London, London, England, USA"},{"name":"Centre for Medicines Optimisation Research and Education (CMORE), University College London Hospitals NHS Foundation Trust, London, England, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR"},{"name":"Department of Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry Y S","family":"Lum","sequence":"additional","affiliation":[{"name":"Department of Social Work and Social Administration, Faculty of Social Science, The University of Hong Kong, Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Luo","sequence":"additional","affiliation":[{"name":"School of Public Health Sciences, Faculty of Health, University of Waterloo, Waterloo, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Rao","sequence":"additional","affiliation":[{"name":"Faculty of Education, The University of Hong Kong, Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Tomlin","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Grafton, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wei","sequence":"additional","affiliation":[{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London, London, England, USA"},{"name":"Centre for Medicines Optimisation Research and Education (CMORE), University College London Hospitals NHS Foundation Trust, London, England, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun K","family":"Wing","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1291-3902","authenticated-orcid":false,"given":"Amy H Y","family":"Chan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Faculty of Medical and Health Sciences, The University of Auckland, Grafton, Auckland, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Chia-Cheng","family":"Lai","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan"},{"name":"Population Health Data Center, National Cheng Kung University, Tainan, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Seoul National University, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8645-1942","authenticated-orcid":false,"given":"Kenneth K C","family":"Man","sequence":"additional","affiliation":[{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London, London, England, USA"},{"name":"Centre for Medicines Optimisation Research and Education (CMORE), University College London Hospitals NHS Foundation Trust, London, England, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C K","family":"Wong","sequence":"additional","affiliation":[{"name":"Aston Pharmacy School, Aston University, West Midlands, Birmingham, USA"},{"name":"Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong SAR"},{"name":"Research Department of Practice and Policy, School of Pharmacy, University College London, London, England, USA"},{"name":"Centre for Medicines Optimisation Research and Education (CMORE), University College London Hospitals NHS Foundation Trust, London, England, USA"},{"name":"School of Pharmacy, Medical Sciences Division, Macau University of Science and Technology, Taipa, Macau"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"2026091201251420000_29.1.e302819.1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7340a1"},{"key":"2026091201251420000_29.1.e302819.2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2215-0366(17)30167-0","article-title":"ADHD in children and young people: prevalence, care pathways, and service provision","volume":"5","author":"Sayal","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2026091201251420000_29.1.e302819.3","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.107.048827"},{"key":"2026091201251420000_29.1.e302819.4","unstructured":"National Health Service, U.K . ADHD in children and young people. 2025. Available: https:\/\/www.nhs.uk\/conditions\/adhd-children-teenagers\/#:~:text=Symptoms%20of%20ADHD%20(attention%20deficit%20hyperactivity%20disorder)&text=They%20involve%20a%20person%E2%80%99s%20ability,their%20impulses%20(being%20impulsive)"},{"key":"2026091201251420000_29.1.e302819.5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S2215-0366(26)00091-X","article-title":"Pharmacological interventions for ADHD: a systematic review and dose-effect network meta-analysis","volume":"13","author":"Nourredine","year":"2026","journal-title":"Lancet Psychiatry"},{"key":"2026091201251420000_29.1.e302819.6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/tp.2017.08.02","article-title":"Pharmacologic management of attention deficit hyperactivity disorder in children and adolescents: a review for practitioners","volume":"7","author":"Brown","year":"2018","journal-title":"Transl Pediatr"},{"key":"2026091201251420000_29.1.e302819.7","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2026091201251420000_29.1.e302819.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2019.12.003"},{"key":"2026091201251420000_29.1.e302819.9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s43440-025-00763-0","article-title":"Current insights into the safety and adverse effects of methylphenidate in children, adolescents, and adults - narrative review","volume":"77","author":"Silczuk","year":"2025","journal-title":"Pharmacol Rep"},{"key":"2026091201251420000_29.1.e302819.10","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamapsychiatry.2017.2183","article-title":"Association of risk of suicide attempts with methylphenidate treatment","volume":"74","author":"Man","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"2026091201251420000_29.1.e302819.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101780","article-title":"Attention-deficit\/hyperactivity disorder medication consumption in 64 countries and regions from 2015 to 2019: a longitudinal study","volume":"58","author":"Chan","year":"2023","journal-title":"EClinicalMedicine"},{"key":"2026091201251420000_29.1.e302819.12","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","article-title":"Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases","volume":"5","author":"Raman","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"2026091201251420000_29.1.e302819.13","unstructured":"Lancet T . The lancet commission on self-harm. 2024. Available: https:\/\/www.thelancet.com\/commissions-do\/lancet-commission-self-harm"},{"key":"2026091201251420000_29.1.e302819.14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043409","article-title":"International study of definitions of English-language terms for suicidal behaviours: a survey exploring preferred terminology","volume":"11","author":"De Leo","year":"2021","journal-title":"BMJ Open"},{"key":"2026091201251420000_29.1.e302819.15","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S149961"},{"key":"2026091201251420000_29.1.e302819.16","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41591-024-02917-8","article-title":"Maternal diabetes and risk of attention-deficit\/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairs","volume":"30","author":"Chan","year":"2024","journal-title":"Nat Med"},{"key":"2026091201251420000_29.1.e302819.17","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"key":"2026091201251420000_29.1.e302819.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-081627","article-title":"Use of gabapentinoid treatment and the risk of self-harm: population based self-controlled case series study","volume":"389","author":"Yuen","year":"2025","journal-title":"BMJ"},{"key":"2026091201251420000_29.1.e302819.19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2352-4642(20)30100-0","article-title":"Association between methylphenidate treatment and risk of seizure: a population-based, self-controlled case-series study","volume":"4","author":"Man","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"2026091201251420000_29.1.e302819.20","doi-asserted-by":"publisher","DOI":"10.1016\/0197-2456(86)90046-2"},{"key":"2026091201251420000_29.1.e302819.21","doi-asserted-by":"publisher","DOI":"10.1002\/sim.7311"},{"key":"2026091201251420000_29.1.e302819.22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD"},{"key":"2026091201251420000_29.1.e302819.23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g3769","article-title":"Drug treatment for attention-deficit\/hyperactivity disorder and suicidal behaviour: register based study","volume":"348","author":"Chen","year":"2014","journal-title":"BMJ"},{"key":"2026091201251420000_29.1.e302819.24","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jamapsychiatry.2025.1281","article-title":"Increased prescribing of attention-deficit\/hyperactivity disorder medication and real-world outcomes over time","volume":"82","author":"Li","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"2026091201251420000_29.1.e302819.25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-083658","article-title":"ADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trials","volume":"390","author":"Zhang","year":"2025","journal-title":"BMJ"},{"key":"2026091201251420000_29.1.e302819.26","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.2859","article-title":"Attention-deficit\/hyperactivity disorder medications and work disability and mental health outcomes","volume":"7","author":"Taipale","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026091201251420000_29.1.e302819.27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5765\/jkacap.220040","article-title":"Systematic review of suicidal behaviors related to methylphenidate and atomoxetine in patients with attention deficit hyperactivity disorder","volume":"34","author":"Kim","year":"2023","journal-title":"J Korean Acad Child Adolesc Psychiatry"},{"key":"2026091201251420000_29.1.e302819.28","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2215-0366(23)00292-4","article-title":"WHO model lists of essential medicines: methylphenidate for ADHD in children and adolescents","volume":"10","author":"Cortese","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"2026091201251420000_29.1.e302819.29","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1738"}],"container-title":["BMJ Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjment-2026-302819","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:25:25Z","timestamp":1789201525000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/bmjment-2026-302819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,9,12]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/bmjment-2026-302819"],"URL":"https:\/\/doi.org\/10.1136\/bmjment-2026-302819","relation":{},"ISSN":["2755-9734"],"issn-type":[{"value":"2755-9734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}